Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized, Active (Warfarin) Controlled, Parallel-arm Clinical Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely and Effectively on Apixaban
Conditions
Interventions
Apixaban 5 MG
Apixaban 2.5 MG
+2 more
Locations
62
United States
Tucson Heart Center
Tucson, Arizona, United States
CHI St. Vincent Heart Institute
Little Rock, Arkansas, United States
Loma Linda University Medical Center
Loma Linda, California, United States
Stanford University Medical Center
Palo Alto, California, United States
Sharp Memorial
San Diego, California, United States
Hartford Hospital
Hartford, Connecticut, United States
Start Date
May 1, 2020
Primary Completion Date
December 12, 2022
Completion Date
December 12, 2022
Last Updated
March 20, 2024
NCT06352671
NCT07001800
NCT06557798
NCT07120048
NCT07477002
NCT07366671
Lead Sponsor
Artivion Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions